may 17, 2018 -- the fda has approved the first in a new class of migraine drugs that aim to fight painful
.
.
victor bwire
.
richard lipton, md, director, montefiore headache center; edwin s. lowe professor and vice chairman of neurology, albert einstein college of medicine.
.